Graft-versus-host disease after bone marrow transplant results from donor immune cells attacking host tissues. This is best described as which type of hypersensitivity reaction?

Prepare for the NBME Form 16 with our comprehensive quiz. Tackle multiple choice questions with insights and explanations. Enhance your confidence and accuracy for the exam!

Multiple Choice

Graft-versus-host disease after bone marrow transplant results from donor immune cells attacking host tissues. This is best described as which type of hypersensitivity reaction?

Explanation:
Graft-versus-host disease is a T-cell–mediated, delayed hypersensitivity reaction. After a bone marrow transplant, donor T lymphocytes recognize the host’s tissues as foreign and mount an immune attack, causing tissue injury—especially in skin, liver, and gut. This injury is driven by T cells and macrophages releasing cytokines, not by antibodies, so it fits the delayed-type (Type IV) pattern. The other hypersensitivity types involve antibodies or immune complexes (Type II and III) or immediate IgE-mediated reactions (Type I), which is why they don’t describe GVHD.

Graft-versus-host disease is a T-cell–mediated, delayed hypersensitivity reaction. After a bone marrow transplant, donor T lymphocytes recognize the host’s tissues as foreign and mount an immune attack, causing tissue injury—especially in skin, liver, and gut. This injury is driven by T cells and macrophages releasing cytokines, not by antibodies, so it fits the delayed-type (Type IV) pattern. The other hypersensitivity types involve antibodies or immune complexes (Type II and III) or immediate IgE-mediated reactions (Type I), which is why they don’t describe GVHD.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy